Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com Prev Post Maiden Drill Program Commences at Oasis Uranium Project July 28, 2025 Next Post UnitedHealth says it faces DOJ investigation over Medicare billing practices July 29, 2025 Related Posts CoTec Holdings October 15, 2025 JZR Gold Announces First Concentrate From Vila Nova Gold Project October 15, 2025 Blackrock Announces Arrangements to Address Mailing of Meeting Materials Resulting from the Canada Post Strike October 15, 2025
Blackrock Announces Arrangements to Address Mailing of Meeting Materials Resulting from the Canada Post Strike October 15, 2025